Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: scott_jiminez who wrote (2093)	11/22/2000 9:04:18 AM
From: Biomaven	Read Replies (1) \| Respond to of 52153

Quite honestly I don't think it makes much difference to most biotechs whether it's Bush or Gore. The two main points of contact between the biotechs and the political system are the FDA and the drug reimbursement system. I can't see the FDA as being much different under either Bush or Gore than it is now. I see a tougher reimbursement policy (really a mild cost-control measure of some sort) under Gore, offset by a bigger total dollar spending on healthcare. I've read the Florida Supreme Court decision, and I see no way the US Supreme Court would overturn it. I sincerely hope the Florida legislature doesn't try to climb into the picture. That way lies real chaos. Peter